ChromaDex Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
ChromaDex Corporation (CDXC)
NASDAQ:AMEX Investor Relations:
investors.chromadex.com
Company Research
Source: Yahoo! Finance
Net loss: US$4.94m (loss narrowed by 70% from FY 2022). US$0.066 loss per share (improved from US$0.24 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period ChromaDex EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 20%. Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Life Sciences industry in the US. Performance of the American Life Sciences industry. The company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on ChromaDex's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.co
Show less
Read more
Impact Snapshot
Event Time:
CDXC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXC alerts
High impacting ChromaDex Corporation news events
Weekly update
A roundup of the hottest topics
CDXC
News
- ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® [Yahoo! Finance]Yahoo! Finance
- ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®Business Wire
- ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 [Yahoo! Finance]Yahoo! Finance
- ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024Business Wire
- ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers MarketBusiness Wire
CDXC
Earnings
- 3/6/24 - Beat
CDXC
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- CDXC's page on the SEC website